콘텐츠로 건너뛰기
Merck
  • Nuclear receptor NR5A2 controls neural stem cell fate decisions during development.

Nuclear receptor NR5A2 controls neural stem cell fate decisions during development.

Nature communications (2016-07-23)
Athanasios Stergiopoulos, Panagiotis K Politis
초록

The enormous complexity of mammalian central nervous system (CNS) is generated by highly synchronized actions of diverse factors and signalling molecules in neural stem/progenitor cells (NSCs). However, the molecular mechanisms that integrate extrinsic and intrinsic signals to control proliferation versus differentiation decisions of NSCs are not well-understood. Here we identify nuclear receptor NR5A2 as a central node in these regulatory networks and key player in neural development. Overexpression and loss-of-function experiments in primary NSCs and mouse embryos suggest that NR5A2 synchronizes cell-cycle exit with induction of neurogenesis and inhibition of astrogliogenesis by direct regulatory effects on Ink4/Arf locus, Prox1, a downstream target of proneural genes, as well as Notch1 and JAK/STAT signalling pathways. Upstream of NR5a2, proneural genes, as well as Notch1 and JAK/STAT pathways control NR5a2 endogenous expression. Collectively, these observations render NR5A2 a critical regulator of neural development and target gene for NSC-based treatments of CNS-related diseases.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Monoclonal Anti-STAT3 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0490, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-NeuN Antibody, clone A60, clone A60, Chemicon®, from mouse